Status:
COMPLETED
Incidence of VAP in Patients With Severe COVID-19
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions:
Ventilator Associated Pneumonia
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Combined retrospective and prospective cohort study to evaluate the incidence of microbiologically confirmed VAP in mechanically ventilated patients with COVID-19. In the retrospective part, microbiol...
Detailed Description
Ventilator-associated pneumoniae (VAP) is the most common infection acquired in the intensive care unit (ICU). To date, there is no diagnostic gold standard for VAP, and its diagnosis is based on scor...
Eligibility Criteria
Inclusion
- Retrospective part all patients admitted to the ICU for COVID-19-related respiratory failure since the beginning of the pandemics will be included.
- Prospective part
- Age ≥ 18 years
- Diagnosis of SARS-CoV-2 infection by means of reverse transcription polymerase chain reaction (RT-PCR)
- Respiratory failure requiring mechanical ventilation
- mechanical ventilation ongoing for less than 48h
Exclusion
- Age \< 18 years
- mechanical ventilation ongoing for more than 48h
Key Trial Info
Start Date :
February 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT04766983
Start Date
February 28 2020
End Date
January 31 2023
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation
Milan, MI, Italy, 20122